Atlas Trials

Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?

Clinical trial NCT06352242 · RECRUITING

Trial details

NCT number
NCT06352242
Sponsor
University Hospital, Montpellier
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Diffuse Large B Cell Lymphoma
Start date
2024-05-22
Primary completion
2027-02-22
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.